MDL | MFCD01310836 |
---|---|
Molecular Weight | 199.25 |
Molecular Formula | C13H13NO |
SMILES | NCC1=CC=C(OC2=CC=CC=C2)C=C1 |
4-Phenoxybenzylamine inhibits the function of the NS3 protein by stabilizing an inactive conformation with an IC 50 of about 500 μM against FL NS3/4a.
IC50: 500 μM (FL NS3/4a) [1]
A highly conserved novel binding site located at the interface between the protease and helicase domains of the Hepatitis C Virus (HCV) NS3 protein is identified. 4-Phenoxybenzylamine binding at this allosteric site inhibits the function of the NS3 protein by stabilizing an inactive conformation and thus represents a new class of direct acting antiviral agents [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Liquid
Room temperature in continental US; may vary elsewhere.
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
DMSO : 12.5 mg/mL ( 62.74 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 5.0188 mL | 25.0941 mL | 50.1882 mL |
5 mM | 1.0038 mL | 5.0188 mL | 10.0376 mL |
10 mM | 0.5019 mL | 2.5094 mL | 5.0188 mL |